Abstract :
Hyperglycemia and insulin resistance resulted from uncontrolled diabetes
mellitus (DM) had has been consistently associated with poor clinical
outcome in patient with ischemic stroke. Hence, early diagnosis of DM,
efficient glycemic control, and prevention of its complications, together
using credible therapeutic approaches, are essential to avoid the stroke
complications and minimize its financial burden. Candidate strategies used
to control glycaemia failed to show an efficacy in stroke patients. Glucagon
like peptide-1 (GLP-1) receptor agonists are novel antidiabetic agents with a
proved neuroprotection effect. Herewith, we review the concept of GLP-1
use as a neuroprotective approach against DM-associated stroke.
Keyword :
Ischemic stroke, diabetes mellitus, Glucagon-like peptide 1, Neuroprotection.